These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20567167)

  • 1. Using computer decision support to increase maternal postpartum tetanus, diphtheria, and acellular pertussis vaccination.
    Trick WE; Linn ES; Jones Z; Caquelin C; Kee R; Morita JY
    Obstet Gynecol; 2010 Jul; 116(1):51-57. PubMed ID: 20567167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Murphy TV; Slade BA; Broder KR; Kretsinger K; Tiwari T; Joyce PM; Iskander JK; Brown K; Moran JS;
    MMWR Recomm Rep; 2008 May; 57(RR-4):1-51. PubMed ID: 18509304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing postpartum rate of vaccination with tetanus, diphtheria, and acellular pertussis vaccine by incorporating pertussis cocooning information into prenatal education for group B streptococcus prevention.
    Cheng PJ; Huang SY; Su SY; Peng HH; Chang CL
    Vaccine; 2015 Dec; 33(51):7225-7231. PubMed ID: 26549365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a Best-Practice Alert and Prenatal Administration With Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccination Rates.
    Morgan JL; Baggari SR; Chung W; Ritch J; McIntire DD; Sheffield JS
    Obstet Gynecol; 2015 Aug; 126(2):333-337. PubMed ID: 26241423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetanus and diphtheria toxoids and acellular pertussis vaccine uptake during pregnancy in a metropolitan tertiary care center.
    Healy CM; Ng N; Taylor RS; Rench MA; Swaim LS
    Vaccine; 2015 Sep; 33(38):4983-7. PubMed ID: 26192356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing Tdap Coverage Among Postpartum Women: A Quality Improvement Intervention.
    Bernstein HH; Monty M; Yang P; Cohen A
    Pediatrics; 2017 Mar; 139(3):. PubMed ID: 28179484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.
    Brandon D; Kimmel M; Kuriyakose SO; Kostanyan L; Mesaros N
    Vaccine; 2018 Oct; 36(42):6325-6333. PubMed ID: 30197282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between social vulnerability and influenza and tetanus-diphtheria-acellular pertussis vaccination in pregnant and postpartum individuals.
    Kiefer MK; Mehl R; Costantine MM; Landon MB; Bartholomew A; Mallampati D; Manuck T; Grobman W; Rood KM; Venkatesh KK
    Am J Obstet Gynecol MFM; 2022 May; 4(3):100603. PubMed ID: 35240346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection.
    Castagnini LA; Healy CM; Rench MA; Wootton SH; Munoz FM; Baker CJ
    Clin Infect Dis; 2012 Jan; 54(1):78-84. PubMed ID: 22075790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
    MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.
    Kretsinger K; Broder KR; Cortese MM; Joyce MP; Ortega-Sanchez I; Lee GM; Tiwari T; Cohn AC; Slade BA; Iskander JK; Mijalski CM; Brown KH; Murphy TV; ; ;
    MMWR Recomm Rep; 2006 Dec; 55(RR-17):1-37. PubMed ID: 17167397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis.
    Terranella A; Asay GR; Messonnier ML; Clark TA; Liang JL
    Pediatrics; 2013 Jun; 131(6):e1748-56. PubMed ID: 23713104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with Tdap vaccination receipt during pregnancy: a cross-sectional study.
    Wales DP; Khan S; Suresh D; Ata A; Morris B
    Public Health; 2020 Feb; 179():38-44. PubMed ID: 31726399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial.
    Sricharoenchai S; Sirivichayakul C; Chokephaibulkit K; Pitisuttithum P; Dhitavat J; Pitisuthitham A; Phongsamart W; Boonnak K; Lapphra K; Sabmee Y; Wittawatmongkol O; Chinwangso P; Poredi IK; Petre J; Thai PH; Viviani S
    Lancet Infect Dis; 2018 Jan; 18(1):58-67. PubMed ID: 29066131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertussis immunization in a high-risk postpartum population.
    Healy CM; Rench MA; Castagnini LA; Baker CJ
    Vaccine; 2009 Sep; 27(41):5599-602. PubMed ID: 19647062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetanus, diphtheria, pertussis vaccination coverage before, during, and after pregnancy - 16 States and New York City, 2011.
    Ahluwalia IB; Ding H; D'Angelo D; Shealy KH; Singleton JA; Liang J; Rosenberg KD;
    MMWR Morb Mortal Wkly Rep; 2015 May; 64(19):522-6. PubMed ID: 25996094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis and patient safety: implementing Tdap vaccine recommendations in hospitals.
    Tan TQ; Gerbie MV
    Jt Comm J Qual Patient Saf; 2010 Apr; 36(4):173-8. PubMed ID: 20402374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Prenatal Versus Postpartum Tetanus, Diphtheria, and Acellular Pertussis Vaccination in Preventing Infant Pertussis.
    Winter K; Nickell S; Powell M; Harriman K
    Clin Infect Dis; 2017 Jan; 64(1):3-8. PubMed ID: 27624955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women.
    Halperin BA; Morris A; Mackinnon-Cameron D; Mutch J; Langley JM; McNeil SA; Macdougall D; Halperin SA
    Clin Infect Dis; 2011 Nov; 53(9):885-92. PubMed ID: 21946190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.